GSK’s Strategy in Emerging Markets: Scale, Diversification and Access

Branded products are key to emerging markets, where they tend to have long lifecycles that extend well beyond patent expiration, GlaxoSmithKline's president of emerging markets Abbas Hussain told investors at a Sanford F. Bernstein conference May 6